Business News

Metabasis Announces Conference Call and Live Webcast to Discuss Second Quarter 2008 Financial Results

2008-07-17 12:14:00

SAN DIEGO–(EMWNews)–Metabasis Therapeutics, (Nasdaq: MBRX) will announce its second quarter

2008 earnings results on Thursday, August 7, 2008, after markets close.

Following the earnings release, Metabasis will hold a conference call

and live webcast at 4:30 p.m. Eastern Time to discuss financial and

other business results. Dr. Paul Laikind, president and chief executive

officer and Mr. Dan Milles, senior director of finance, will participate

in the call. Dr. Howard Foyt, vice president of clinical development,

will also be available to answer questions.

The conference call may be accessed by dialing 866-825-3308 for domestic

callers and 617-213-8062 for international callers. Please specify to

the operator Metabasis Therapeutics

when asked for a passcode. The conference call will be webcast live on

the Metabasis website at,

under the Investors section, and will be archived there for 30 days

following the call. Please connect to Metabasis

website several minutes prior to the start of the call to ensure

adequate time for any software download that may be necessary.

About Metabasis (

Metabasis is a biopharmaceutical company using its proprietary

technologies, scientific expertise and unique capabilities for targeting

the liver and liver pathways. The Company has established a broad

pipeline of product candidates and advanced research programs targeting

large markets with significant unmet needs. Metabasis’ core area of

focus is on the discovery and development of drug candidates to treat

metabolic diseases such as hyperlipidemia and diabetes, among others.

Although not a core focus of the Company, Metabasis has also discovered

and developed drug candidates indicated for the treatment of liver

diseases such as hepatitis and primary liver cancer, which it now

intends to license or partner. All product candidates were developed

internally using proprietary technologies.

Metabasis Therapeutics, Inc.
Constance Bienfait, 858-622-5575

Investor Relations & Corporate Communications

free cash grants, free grant money, free money, cash grants, scholarships, business grants, foundation grants, government grants, debt grants, consolidation, college tuition, financial aid, medical grants, personal grants, medical bills, unsecured loans, no interest loans, financing, loans, capital, non profit organizations

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website now offers Organic Lead Generation & Traffic Solutions

Jordan Taylor

Jordan Taylor is Sr. Editor & writer from San Diego, CA. With over 20 years and 2650+ articles edited rest assured your Press Release will see traction.

Related Articles

Back to top button